<?xml version="1.0" encoding="UTF-8"?>
<document id="28290464">
	<sentence id="s1" text="Naive CD4+ T cells adhere to tumor slices in proportion to the abundance of monocyte chemotaxis-producing macrophages.">
		<entity id="s1.e1" charOffset="29-34"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="76-95"
			type="GO" text="monocyte chemotaxis" ontology_id="GO_0002548"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Moreover, adoptively transferred human naive CD4+ T cells infiltrate human breast cancer orthotopic xenografts in a monocyte chemotaxis-dependent manner.">
		<entity id="s2.e1" charOffset="82-88"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e2" charOffset="116-135"
			type="GO" text="monocyte chemotaxis" ontology_id="GO_0002548"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4+ T cells into tumor by knocking down the expression of ER to Golgi vesicle-mediated transport, a monocyte chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
		<entity id="s3.e1" charOffset="16-22"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="105-110"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s3.e3" charOffset="146-184"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<entity id="s3.e4" charOffset="157-176"
			type="GO" text="monocyte chemotaxis" ontology_id="GO_0002548"/>
		<pair id="s3.p1" e1="s3.e4"
		    e2="s3.e4" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p3" e1="s3.e1"
		    e2="s3.e4" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Inhibiting naive CD4+ T cell recruitment into tumors by interfering with ER to Golgi vesicle-mediated transport recognition of monocyte chemotaxis may be an attractive strategy for anticancer immunotherapy">
		<entity id="s4.e1" charOffset="46-51"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s4.e2" charOffset="73-111"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<entity id="s4.e3" charOffset="96-115"
			type="GO" text="monocyte chemotaxis" ontology_id="GO_0002548"/>
		<entity id="s4.e4" charOffset="154-160"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
		<pair id="s4.p3" e1="s4.e3"
		    e2="s4.e4" pgr="false"/>
		<pair id="s4.p4" e1="s4.e4"
		    e2="s4.e6" pgr="false"/>
	</sentence>
	<sentence id="s5" text="In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4+ T cells into tumor by knocking down the expression of ER to Golgi vesicle-mediated transport, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.">
		<entity id="s5.e1" charOffset="16-22"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e2" charOffset="146-184"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
</document>
